# Immuneering Corp: filings

IMRX · Nasdaq · CIK 1790340 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/imrx.md) · [Financials](/companies/imrx/financials.md) · [Filings](/companies/imrx/filings.md) · [Insiders](/companies/imrx/insiders.md)

## Reports and events: 78 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 143, 8-K 46, 3 18, SC 13G/A 18, 10-Q 17, CORRESP 8, SC 13G 7, 424B5 6, UPLOAD 6, 10-K 5, DEF 14A 5, DEFA14A 5, EFFECT 4, D 3, S-3 3, SCHEDULE 13G 3, SCHEDULE 13G/A 3, 8-K/A 2, FWP 2, S-1/A 2, S-8 2, 144 1, 3/A 1, 424B3 1, 424B4 1, 5 1, 8-A12B 1, CERT 1, D/A 1, DRS 1, DRS/A 1, DRSLTR 1, S-1 1, S-1MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:22 ET | [10-Q](/filings/0001790340-26-000097.md) | Quarterly report, period 2026-09-30 | 0001790340-26-000097 |
| 2026-10-29 | 16:12 ET | [8-K](/filings/0001790340-26-000095.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-26-000095 |
| 2026-08-05 | 07:57 ET | [10-Q](/filings/0001790340-26-000091.md) | Quarterly report, period 2026-06-30 | 0001790340-26-000091 |
| 2026-08-05 | 07:41 ET | [8-K](/filings/0001790340-26-000088.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-26-000088 |
| 2026-06-15 | 16:12 ET | [8-K](/filings/0001790340-26-000074.md) | 5.02 Departure or appointment of officers or directors | 0001790340-26-000074 |
| 2026-06-11 | 17:16 ET | [8-K](/filings/0001790340-26-000062.md) | 5.07 Shareholder vote results | 0001790340-26-000062 |
| 2026-06-01 | 16:51 ET | [8-K](/filings/0001790340-26-000059.md) | 8.01 Other events | 0001790340-26-000059 |
| 2026-05-15 | 07:52 ET | [10-Q](/filings/0001790340-26-000057.md) | Quarterly report, period 2026-03-31 | 0001790340-26-000057 |
| 2026-05-15 | 07:43 ET | [8-K](/filings/0001790340-26-000055.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-26-000055 |
| 2026-04-20 | 16:10 ET | [DEF 14A](/filings/0001790340-26-000048.md) | Proxy statement, period 2026-04-20 | 0001790340-26-000048 |
| 2026-03-06 | 08:29 ET | [10-K](/filings/0001790340-26-000042.md) | Annual report, period 2025-12-31 | 0001790340-26-000042 |
| 2026-03-06 | 08:09 ET | [8-K](/filings/0001790340-26-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-26-000040 |
| 2026-01-07 | 16:10 ET | [8-K](/filings/0001790340-26-000006.md) | 8.01 Other events | 0001790340-26-000006 |
| 2025-11-12 | 16:19 ET | [10-Q](/filings/0001790340-25-000135.md) | Quarterly report, period 2025-09-30 | 0001790340-25-000135 |
| 2025-11-12 | 16:07 ET | [8-K](/filings/0001790340-25-000133.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-25-000133 |
| 2025-09-25 | 17:23 ET | [8-K](/filings/0001104659-25-093436.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-093436 |
| 2025-09-24 | 16:15 ET | [8-K](/filings/0001104659-25-092957.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-092957 |
| 2025-08-25 | 20:58 ET | [8-K](/filings/0001104659-25-081995.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-081995 |
| 2025-08-13 | 16:25 ET | [10-Q](/filings/0001790340-25-000104.md) | Quarterly report, period 2025-06-30 | 0001790340-25-000104 |
| 2025-08-13 | 16:13 ET | [8-K](/filings/0001790340-25-000102.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-25-000102 |
| 2025-06-17 | 06:09 ET | [8-K](/filings/0001790340-25-000077.md) | 8.01 Other events | 0001790340-25-000077 |
| 2025-06-16 | 08:44 ET | [8-K](/filings/0001790340-25-000063.md) | 5.07 Shareholder vote results | 0001790340-25-000063 |
| 2025-05-05 | 16:34 ET | [10-Q](/filings/0001790340-25-000061.md) | Quarterly report, period 2025-03-31 | 0001790340-25-000061 |
| 2025-05-05 | 16:17 ET | [8-K](/filings/0001790340-25-000059.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-25-000059 |
| 2025-04-21 | 16:50 ET | [DEF 14A](/filings/0001790340-25-000053.md) | Proxy statement, period 2025-04-21 | 0001790340-25-000053 |
| 2025-03-20 | 16:47 ET | [10-K](/filings/0001790340-25-000042.md) | Annual report, period 2024-12-31 | 0001790340-25-000042 |
| 2025-03-20 | 16:07 ET | [8-K](/filings/0001790340-25-000039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-25-000039 |
| 2025-01-13 | 16:36 ET | [8-K](/filings/0001790340-25-000014.md) | 8.01 Other events | 0001790340-25-000014 |
| 2025-01-07 | 08:26 ET | [8-K](/filings/0001790340-25-000012.md) | 8.01 Other events | 0001790340-25-000012 |
| 2024-11-13 | 16:09 ET | [10-Q](/filings/0001790340-24-000080.md) | Quarterly report, period 2024-09-30 | 0001790340-24-000080 |
| 2024-11-13 | 16:04 ET | [8-K](/filings/0001790340-24-000078.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-24-000078 |
| 2024-10-02 | 16:11 ET | [8-K/A](/filings/0001790340-24-000073.md) | 5.02 Departure or appointment of officers or directors | 0001790340-24-000073 |
| 2024-09-12 | 16:11 ET | [8-K](/filings/0001790340-24-000069.md) | 8.01 Other events | 0001790340-24-000069 |
| 2024-08-06 | 16:12 ET | [10-Q](/filings/0001790340-24-000066.md) | Quarterly report, period 2024-06-30 | 0001790340-24-000066 |
| 2024-08-06 | 16:07 ET | [8-K](/filings/0001790340-24-000064.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-24-000064 |
| 2024-06-13 | 16:09 ET | [8-K](/filings/0001790340-24-000060.md) | 5.07 Shareholder vote results | 0001790340-24-000060 |
| 2024-05-23 | 16:10 ET | [8-K](/filings/0001790340-24-000058.md) | 5.02 Departure or appointment of officers or directors | 0001790340-24-000058 |
| 2024-05-07 | 16:09 ET | [10-Q](/filings/0001790340-24-000056.md) | Quarterly report, period 2024-03-31 | 0001790340-24-000056 |
| 2024-05-07 | 16:04 ET | [8-K](/filings/0001790340-24-000054.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-24-000054 |
| 2024-04-23 | 16:12 ET | [DEF 14A](/filings/0001790340-24-000044.md) | Proxy statement, period 2024-04-23 | 0001790340-24-000044 |
| 2024-03-14 | 07:04 ET | [8-K](/filings/0001104659-24-034204.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001104659-24-034204 |
| 2024-03-01 | 08:05 ET | [10-K](/filings/0001790340-24-000024.md) | Annual report, period 2023-12-31 | 0001790340-24-000024 |
| 2024-03-01 | 07:58 ET | [8-K](/filings/0001790340-24-000022.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-24-000022 |
| 2024-02-02 | 16:15 ET | [8-K](/filings/0001104659-24-010041.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-24-010041 |
| 2023-11-09 | 16:12 ET | [10-Q](/filings/0001790340-23-000056.md) | Quarterly report, period 2023-09-30 | 0001790340-23-000056 |
| 2023-11-09 | 16:05 ET | [8-K](/filings/0001790340-23-000054.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-23-000054 |
| 2023-08-03 | 16:10 ET | [10-Q](/filings/0001790340-23-000048.md) | Quarterly report, period 2023-06-30 | 0001790340-23-000048 |
| 2023-08-03 | 16:04 ET | [8-K](/filings/0001790340-23-000046.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001790340-23-000046 |
| 2023-06-15 | 16:15 ET | [8-K](/filings/0001790340-23-000029.md) | 5.07 Shareholder vote results | 0001790340-23-000029 |
| 2023-06-14 | 16:08 ET | [8-K](/filings/0001790340-23-000025.md) | 5.02 Departure or appointment of officers or directors | 0001790340-23-000025 |

Page 1 of 2. [Older](/companies/imrx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 18:24 ET. No prices; not investment advice.